David Meek, Mirati CEO (Marlene Awaad/Bloomberg via Getty Images)

Mi­rati gaug­ing sale in­ter­est of Big Phar­mas — re­port

Mi­rati Ther­a­peu­tics, mak­er of the ex­per­i­men­tal can­cer drug ada­gra­sib, is piquing the in­ter­est of Big Phar­mas, ac­cord­ing to a re­port from Bloomberg.

On Tues­day, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.